UniProt ID | RC3H2_HUMAN | |
---|---|---|
UniProt AC | Q9HBD1 | |
Protein Name | Roquin-2 | |
Gene Name | RC3H2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1191 | |
Subcellular Localization | Cytoplasm, P-body. During stress, such as that induced by arsenite, localizes to cytosolic stress granules. Localization to stress granules, but not to P-bodies, depends upon the RING-type zinc finger. | |
Protein Description | Post-transcriptional repressor of mRNAs containing a conserved stem loop motif, called constitutive decay element (CDE), which is often located in the 3'-UTR, as in HMGXB3, ICOS, IER3, NFKBID, NFKBIZ, PPP1R10, TNF and in many more mRNAs. Binds to CDE and promotes mRNA deadenylation and degradation. This process does not involve miRNAs. In follicular helper T (Tfh) cells, represses of ICOS and TNFRSF4 expression, thus preventing spontaneous Tfh cell differentiation, germinal center B-cell differentiation in the absence of immunization and autoimmunity. In resting or LPS-stimulated macrophages, controls inflammation by suppressing TNF expression. Also recognizes CDE in its own mRNA and in that of paralogous RC3H1, possibly leading to feedback loop regulation (By similarity). miRNA-binding protein that regulates microRNA homeostasis. Enhances DICER-mediated processing of pre-MIR146a but reduces mature MIR146a levels through an increase of 3' end uridylation. Both inhibits ICOS mRNA expression and they may act together to exert the suppression. [PubMed: 25697406 Acts as a ubiquitin E3 ligase. Pairs with E2 enzymes UBE2B, UBE2D2, UBE2E2, UBE2E3, UBE2G2, UBE2K and UBE2Q2 and produces polyubiquitin chains] | |
Protein Sequence | MPVQAAQWTEFLSCPICYNEFDENVHKPISLGCSHTVCKTCLNKLHRKACPFDQTAINTDIDVLPVNFALLQLVGAQVPDHQSIKLSNLGENKHYEVAKKCVEDLALYLKPLSGGKGVASLNQSALSRPMQRKLVTLVNCQLVEEEGRVRAMRAARSLGERTVTELILQHQNPQQLSANLWAAVRARGCQFLGPAMQEEALKLVLLALEDGSALSRKVLVLFVVQRLEPRFPQASKTSIGHVVQLLYRASCFKVTKRDEDSSLMQLKEEFRSYEALRREHDAQIVHIAMEAGLRISPEQWSSLLYGDLAHKSHMQSIIDKLQSPESFAKSVQELTIVLQRTGDPANLNRLRPHLELLANIDPNPDAVSPTWEQLENAMVAVKTVVHGLVDFIQNYSRKGHETPQPQPNSKYKTSMCRDLRQQGGCPRGTNCTFAHSQEELEKYRLRNKKINATVRTFPLLNKVGVNNTVTTTAGNVISVIGSTETTGKIVPSTNGISNAENSVSQLISRSTDSTLRALETVKKVGKVGANGQNAAGPSADSVTENKIGSPPKTPVSNVAATSAGPSNVGTELNSVPQKSSPFLTRVPVYPPHSENIQYFQDPRTQIPFEVPQYPQTGYYPPPPTVPAGVAPCVPRFVRSNNVPESSLPPASMPYADHYSTFSPRDRMNSSPYQPPPPQPYGPVPPVPSGMYAPVYDSRRIWRPPMYQRDDIIRSNSLPPMDVMHSSVYQTSLRERYNSLDGYYSVACQPPSEPRTTVPLPREPCGHLKTSCEEQIRRKPDQWAQYHTQKAPLVSSTLPVATQSPTPPSPLFSVDFRADFSESVSGTKFEEDHLSHYSPWSCGTIGSCINAIDSEPKDVIANSNAVLMDLDSGDVKRRVHLFETQRRTKEEDPIIPFSDGPIISKWGAISRSSRTGYHTTDPVQATASQGSATKPISVSDYVPYVNAVDSRWSSYGNEATSSAHYVERDRFIVTDLSGHRKHSSTGDLLSLELQQAKSNSLLLQREANALAMQQKWNSLDEGRHLTLNLLSKEIELRNGELQSDYTEDATDTKPDRDIELELSALDTDEPDGQSEPIEEILDIQLGISSQNDQLLNGMAVENGHPVQQHQKEPPKQKKQSLGEDHVILEEQKTILPVTSCFSQPLPVSISNASCLPITTSVSAGNLILKTHVMSEDKNDFLKPVANGKMVNS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
120 | Phosphorylation | SGGKGVASLNQSALS CCCCCHHHCCHHHHC | 26.00 | 24719451 | |
212 | Phosphorylation | LLALEDGSALSRKVL HHHHCCCCHHHHHHH | 38.06 | 23403867 | |
215 | Phosphorylation | LEDGSALSRKVLVLF HCCCCHHHHHHHHHH | 29.76 | 23403867 | |
250 | Phosphorylation | VQLLYRASCFKVTKR HHHHHHHHCEECEEC | 15.87 | 19413330 | |
453 | Phosphorylation | RNKKINATVRTFPLL HCCCCCCEEECHHCC | 13.16 | 20363803 | |
471 | O-linked_Glycosylation | GVNNTVTTTAGNVIS CCCCCEEECCCCEEE | 15.43 | 30059200 | |
472 | O-linked_Glycosylation | VNNTVTTTAGNVISV CCCCEEECCCCEEEE | 24.17 | 30059200 | |
497 | O-linked_Glycosylation | VPSTNGISNAENSVS CCCCCCCCCCCHHHH | 31.24 | 30059200 | |
514 | Phosphorylation | ISRSTDSTLRALETV HHCCHHHHHHHHHHH | 24.07 | - | |
549 | Phosphorylation | VTENKIGSPPKTPVS CCCCCCCCCCCCCCC | 41.31 | 25159151 | |
553 | Phosphorylation | KIGSPPKTPVSNVAA CCCCCCCCCCCCCCC | 34.40 | 25159151 | |
556 | Phosphorylation | SPPKTPVSNVAATSA CCCCCCCCCCCCCCC | 27.13 | 23927012 | |
561 | Phosphorylation | PVSNVAATSAGPSNV CCCCCCCCCCCCCCC | 14.90 | 23927012 | |
562 | Phosphorylation | VSNVAATSAGPSNVG CCCCCCCCCCCCCCC | 26.88 | 23403867 | |
566 | Phosphorylation | AATSAGPSNVGTELN CCCCCCCCCCCCCCC | 43.14 | 23403867 | |
579 | Phosphorylation | LNSVPQKSSPFLTRV CCCCCCCCCCCEECC | 37.69 | 27251275 | |
580 | Phosphorylation | NSVPQKSSPFLTRVP CCCCCCCCCCEECCC | 27.06 | 21815630 | |
584 | Phosphorylation | QKSSPFLTRVPVYPP CCCCCCEECCCCCCC | 29.96 | 24719451 | |
593 | O-linked_Glycosylation | VPVYPPHSENIQYFQ CCCCCCCCCCCCCCC | 37.80 | 30059200 | |
662 | Phosphorylation | ADHYSTFSPRDRMNS CCCCCCCCCCCCCCC | 21.08 | 24719451 | |
666 | Methylation | STFSPRDRMNSSPYQ CCCCCCCCCCCCCCC | 27.71 | 30762627 | |
666 | Dimethylation | STFSPRDRMNSSPYQ CCCCCCCCCCCCCCC | 27.71 | - | |
669 | Phosphorylation | SPRDRMNSSPYQPPP CCCCCCCCCCCCCCC | 24.28 | 28555341 | |
670 | Phosphorylation | PRDRMNSSPYQPPPP CCCCCCCCCCCCCCC | 23.71 | 28555341 | |
691 | Phosphorylation | PPVPSGMYAPVYDSR CCCCCCCCCCCCCCC | 15.98 | - | |
714 | Phosphorylation | QRDDIIRSNSLPPMD CCCHHHHCCCCCCHH | 21.99 | 28348404 | |
716 | Phosphorylation | DDIIRSNSLPPMDVM CHHHHCCCCCCHHHC | 43.42 | 28348404 | |
726 | O-linked_Glycosylation | PMDVMHSSVYQTSLR CHHHCCCHHHHHHHH | 15.34 | 30059200 | |
736 | Phosphorylation | QTSLRERYNSLDGYY HHHHHHHHHHCCCEE | 12.35 | 29978859 | |
738 | Phosphorylation | SLRERYNSLDGYYSV HHHHHHHHCCCEEEE | 20.92 | 29978859 | |
742 | Phosphorylation | RYNSLDGYYSVACQP HHHHCCCEEEEEECC | 7.70 | 27642862 | |
743 | Phosphorylation | YNSLDGYYSVACQPP HHHCCCEEEEEECCC | 11.38 | 27642862 | |
755 | O-linked_Glycosylation | QPPSEPRTTVPLPRE CCCCCCCCCCCCCCC | 42.75 | 30059200 | |
768 | Methylation | REPCGHLKTSCEEQI CCCCCCCCCCHHHHH | 32.49 | 115973179 | |
778 | Ubiquitination | CEEQIRRKPDQWAQY HHHHHHHCHHHHHHH | 43.00 | - | |
794 | Phosphorylation | TQKAPLVSSTLPVAT HCCCCCEECCCCCCC | 25.86 | 27732954 | |
795 | Phosphorylation | QKAPLVSSTLPVATQ CCCCCEECCCCCCCC | 26.87 | 27732954 | |
796 | Phosphorylation | KAPLVSSTLPVATQS CCCCEECCCCCCCCC | 27.81 | 27732954 | |
801 | Phosphorylation | SSTLPVATQSPTPPS ECCCCCCCCCCCCCC | 29.79 | 29255136 | |
803 | Phosphorylation | TLPVATQSPTPPSPL CCCCCCCCCCCCCCC | 26.79 | 29255136 | |
805 | Phosphorylation | PVATQSPTPPSPLFS CCCCCCCCCCCCCEE | 53.75 | 29255136 | |
808 | Phosphorylation | TQSPTPPSPLFSVDF CCCCCCCCCCEEEEE | 35.12 | 29255136 | |
812 | Phosphorylation | TPPSPLFSVDFRADF CCCCCCEEEEEECCC | 28.58 | 29255136 | |
834 | Phosphorylation | KFEEDHLSHYSPWSC CCCCCCHHHCCCCCC | 19.57 | 25627689 | |
837 | Phosphorylation | EDHLSHYSPWSCGTI CCCHHHCCCCCCHHH | 17.92 | 25627689 | |
871 | Phosphorylation | AVLMDLDSGDVKRRV CEEEECCCCCHHHHE | 44.16 | 24719451 | |
875 | Ubiquitination | DLDSGDVKRRVHLFE ECCCCCHHHHEEHHH | 38.95 | - | |
883 | O-linked_Glycosylation | RRVHLFETQRRTKEE HHEEHHHHCCCCCCC | 21.75 | 30059200 | |
887 | O-linked_Glycosylation | LFETQRRTKEEDPII HHHHCCCCCCCCCCC | 45.02 | 30059200 | |
888 | Ubiquitination | FETQRRTKEEDPIIP HHHCCCCCCCCCCCC | 58.24 | - | |
897 | O-linked_Glycosylation | EDPIIPFSDGPIISK CCCCCCCCCCCCEEC | 35.98 | 30059200 | |
903 | O-linked_Glycosylation | FSDGPIISKWGAISR CCCCCCEECCCCCCC | 24.07 | 30059200 | |
909 | O-linked_Glycosylation | ISKWGAISRSSRTGY EECCCCCCCCCCCCC | 26.10 | 30059200 | |
932 | Phosphorylation | TASQGSATKPISVSD CCCCCCCCCCCCHHH | 38.76 | 28555341 | |
954 | Phosphorylation | VDSRWSSYGNEATSS ECCCHHHCCCCCCCC | 20.60 | 29978859 | |
959 | Phosphorylation | SSYGNEATSSAHYVE HHCCCCCCCCCEEEE | 19.62 | 28796482 | |
960 | Phosphorylation | SYGNEATSSAHYVER HCCCCCCCCCEEEEC | 32.35 | 28796482 | |
960 | O-linked_Glycosylation | SYGNEATSSAHYVER HCCCCCCCCCEEEEC | 32.35 | 30059200 | |
961 | Phosphorylation | YGNEATSSAHYVERD CCCCCCCCCEEEECC | 18.08 | 28796482 | |
964 | Phosphorylation | EATSSAHYVERDRFI CCCCCCEEEECCEEE | 12.06 | 28796482 | |
976 | Phosphorylation | RFIVTDLSGHRKHSS EEEEECCCCCCCCCC | 35.05 | 28555341 | |
982 | Phosphorylation | LSGHRKHSSTGDLLS CCCCCCCCCCCCHHH | 32.41 | 23401153 | |
983 | Phosphorylation | SGHRKHSSTGDLLSL CCCCCCCCCCCHHHH | 35.81 | 23927012 | |
984 | Phosphorylation | GHRKHSSTGDLLSLE CCCCCCCCCCHHHHH | 37.42 | 25159151 | |
989 | Phosphorylation | SSTGDLLSLELQQAK CCCCCHHHHHHHHHH | 27.39 | 23403867 | |
996 | Ubiquitination | SLELQQAKSNSLLLQ HHHHHHHHCCCHHHH | 45.92 | - | |
999 | Phosphorylation | LQQAKSNSLLLQREA HHHHHCCCHHHHHHH | 27.73 | 22985185 | |
1014 | Ubiquitination | NALAMQQKWNSLDEG HHHHHHHHHHHCHHC | 31.30 | - | |
1017 | Phosphorylation | AMQQKWNSLDEGRHL HHHHHHHHCHHCHHH | 35.76 | 21815630 | |
1030 | Phosphorylation | HLTLNLLSKEIELRN HHHHHHHHHHHHHHC | 31.26 | 28555341 | |
1031 | Ubiquitination | LTLNLLSKEIELRNG HHHHHHHHHHHHHCC | 63.78 | - | |
1044 | Phosphorylation | NGELQSDYTEDATDT CCCCCCCCCCCCCCC | 19.78 | 27642862 | |
1119 | Phosphorylation | PPKQKKQSLGEDHVI CCHHHCCCCCCCCEE | 47.42 | 29255136 | |
1168 | Ubiquitination | SAGNLILKTHVMSED CCCCEEEEEECCCCC | 29.59 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RC3H2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RC3H2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRIM8_HUMAN | TRIM8 | physical | 22493164 | |
RC3H2_HUMAN | RC3H2 | physical | 26489670 | |
UBC_HUMAN | UBC | physical | 26489670 | |
UB2E2_HUMAN | UBE2E2 | physical | 26489670 | |
UB2E3_HUMAN | UBE2E3 | physical | 26489670 | |
UBE2K_HUMAN | UBE2K | physical | 26489670 | |
UB2Q2_HUMAN | UBE2Q2 | physical | 26489670 | |
UBE2B_HUMAN | UBE2B | physical | 26489670 | |
UB2D2_HUMAN | UBE2D2 | physical | 26489670 | |
UB2G2_HUMAN | UBE2G2 | physical | 26489670 | |
UBE2N_HUMAN | UBE2N | physical | 26489670 | |
UB2V1_HUMAN | UBE2V1 | physical | 26489670 | |
UB2V2_HUMAN | UBE2V2 | physical | 26489670 | |
CP19A_HUMAN | CYP19A1 | physical | 28514442 | |
ACTBL_HUMAN | ACTBL2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-549, AND MASSSPECTROMETRY. |